BTA 0.00% 57.0¢ biota holdings limited

No wonder Relenza has bugger all salesThe GSK sales force has...

  1. 1,116 Posts.

    No wonder Relenza has bugger all sales

    The GSK sales force has given up trying to sell Relenza coz they have found it to be ineffective when people try to inject it

    And the cost of supplying a sharps disposal container with every pack of Relenza sold was deemed too expensive

    I must say they are right, because I am really struggling to inject the Relenza I bought off EBAY (the only stockist left).

    Trying to work out how to inject Relenza is like finding a needle in a haystack

    And while I am at it lets forget about finding a cure for the common cold because the only thing that matters is how easy it is to take. Vix Vapodrop & Strepsils and have the ease of use market covered - pity they don't work.

    Efficacy is irrelevant - look at how well the easy to take Tamiflu has done.

    I hope our number two man is not behind the decision to shift away from developing our common cold cure candidate

    Anyone heard a peep from our esteeme chairman Jim Fox lately? - last October he said we'd all be rich


 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.